EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer

References

• Ackerson CJ, Jadzinsky PD, Jensen GJ, Kornberg RD. 2006. Rigid, specific, and discrete gold nanoparticle/antibody conjugates. JACS. 128:2635–2640.
   PubMed Web of Science ®Google Scholar
• Ballot S, Noiret N, Hindre F, Denizot B, Garin E, Rajerison H, Benoit JP. 2006. Tc-99m/(188)re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: Formulation and biodistribution. Eur J Nucl Med Mol Imaging. 33:602–607.
   PubMed Web of Science ®Google Scholar
• Bouchat V, Nuttens VE, Michiels C, Masereel B, Feron O, Gallez B, Vander Borght T, Lucas S. 2010. Radioimmunotherapy with radioactive nanoparticles: Biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area. Med Phys. 37:1826–1839.
   PubMed Web of Science ®Google Scholar
• Cao-Milán R, Liz-Marzán LM. 2014. Gold nanoparticle conjugates: Recent advances toward clinical applications. Expert Opin Drug Del. 11:741–752.
   PubMed Web of Science ®Google Scholar
• Chen P, Cameron R, Wang J, Vallis KA, Reilly RM. 2003. Antitumor effects and normal tissue toxicity of In-111-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. J Nucl Med. 44:1469–1478.
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nat Biotechnol. 25:1165–1170.
   PubMed Web of Science ®Google Scholar
• Cornelissen B, Darbar S, Hernandez R, Kersemans V, Tullis I, Barber PR, Smart S, Vojnovic B, Reilly R, Vallis KA. 2011. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance In-111-DTPA-hEGF Auger electron radiation therapy. J Nucl Med. 52:776–783.
   PubMed Web of Science ®Google Scholar
• Eblan MJ, Wang AZ. 2013. Improving chemoradiotherapy with nanoparticle therapeutics. Transl Cancer Res. 2:320–329.
   PubMed Web of Science ®Google Scholar
• Eckerman KF, Endo A. 2008. MIRD: Radionuclide data and decay schemes. Reston (VA): Society of Nuclear Medicine.
   Google Scholar
• Freudenberg R, Runge R, Maucksch U, Berger V, Kotzerke J. 2014. On the dose calculation at the cellular level and its implications for the RBE of Tc-99m and I-123. Med Phys. 41:062503.
   PubMed Web of Science ®Google Scholar
• Goddu SM, Budinger TF. 1997. MIRD cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston (VA): Society of Nuclear Medicine.
   Google Scholar
• Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavatz JM, Langer R. 2012. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Del Rev. 64:316–326.
   Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. 2008. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 60:977–985.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Smilowitz HM, O’Connor MJ, Dilmanian FA, Slatkin DN. 2013. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine. 8:1601–1609.
   PubMed Web of Science ®Google Scholar
• Hill HD, Millstone JE, Banholzer MJ, Mirkin CA. 2009. The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano. 3:418–424.
   PubMed Web of Science ®Google Scholar
• Hoang B, Reilly RM, Allen C. 2012. Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells. Biomacromolecules. 13:455–465.
   PubMed Web of Science ®Google Scholar
• Hong H, Zhang Y, Sun JT, Cai WB. 2009. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today. 4:399–413.
   PubMed Web of Science ®Google Scholar
• Hua M, Scollard D, Chan C, Chen P, Vallis K, Reilly RM. 2007. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [In-111]DTPA-hEGF. Nucl Med Biol. 34:887–896.
   PubMed Web of Science ®Google Scholar
• Joshi HM, Bhumkar DR, Joshi K, Pokharkar V, Sastry M. 2006. Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir. 22:300–305.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang HQ, Dever B, Li XF, Le XC. 2013. Thermal stability of DNA functionalized gold nanoparticles. Bioconjugate Chem. 24:1790–1797.
   PubMed Web of Science ®Google Scholar
• Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L. 2010. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res. 16:6139–6149.
   PubMed Web of Science ®Google Scholar
• Lin SY, Makino K, Xia WY, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 3:802–808.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release. 65:271–284.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, Mclaughlin RE, Tamarkin L. 2004. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11:169–183.
   PubMed Web of Science ®Google Scholar
• Pouget JP, Lozza C, Deshayes E, Boudousq V, Navarro-Teulon I. 2015. Introduction to radiobiology of targeted radionuclide therapy. Front Med (Lausanne). 2:12.
   PubMedGoogle Scholar
• Rana S, Bajaj A, Mout R, Rotello VM. 2012. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Del Rev. 64:200–216.
   PubMed Web of Science ®Google Scholar
• Reilly RM, Gariepy J. 1998. Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical. J Nucl Med. 39:1036–1043.
   PubMed Web of Science ®Google Scholar
• Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A, Gariepy J. 2000. In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med. 41:429–438.
   PubMed Web of Science ®Google Scholar
• Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA. 2006. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 312:1027–1030.
   PubMed Web of Science ®Google Scholar
• Salvat F, Fernndez-Varena J, Sampau J. 2011. Penelope-2011, a code system for Monte Carlo simulation of electron and photon transport, OECD. Issy les Moulineaux, France: NEA Data Bank.
   Google Scholar
• Song L, Ho VHB, Chen C, Yang ZQ, Liu DS, Chen RJ, Zhou DJ. 2013. Efficient, pH-triggered drug delivery using a pH-responsive DNA-conjugated gold nanoparticle. Adv Healthc Mater. 2:275–280.
   PubMed Web of Science ®Google Scholar
• Steiner M, Neri D. 2011. Antibody-radionuclide conjugates for cancer therapy: Historical considerations and new trends. Clin Cancer Res. 17:6406–6416.
   PubMed Web of Science ®Google Scholar
• Vallis KA, Reilly RM, Scollard D, Merante P, Brade A, Velauthapillai S, Caldwell C, Chan I, Freeman M, Lockwood G, Miller NA, Cornelissen B, Petronis J, Sabate K. 2014. Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer. Am J Nucl Med Mol Imaging. 4:181–192.
   PubMedGoogle Scholar
• Ventola CL. 2012. The nanomedicine revolution: Part 2. Current and future clinical applications. PT. 37:582–591.
   PubMedGoogle Scholar
• Xing Y, Zhao JH, Conti PS, Chen K. 2014. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 4:290–306.
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Tam J, Kuroda S, Scott AW, Aaron J, Larson T, Shanker M, Correa AM, Kondo S, Roth JA, Sokolov K, Ramesh R. 2011. EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One. 6:e25507.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Chen S, Paunesku T, Gleber SC, Liu WC, Doty CB, Mak R, Deng JJ, Jin QL, Lai B, Brister K, Flachenecker C, Jacobsen C, Vogt S, Woloschak GE. 2013. Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells. ACS Nano. 7:10502–10517.
   PubMed Web of Science ®Google Scholar